Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5526
SOPHiA GENETICS
SOPH
$477M
| $229K | ﹤0.01% |
46,547
-45,563
| -49% | -$220K |
|
5527
Wrap Technologies
WRAP
$106M
| $228K | ﹤0.01% |
101,101
-46,161
| -31% | -$156K |
|
5528
Twin Disc
TWIN
$334M
| $228K | ﹤0.01% |
13,774
-4,192
| -23% | -$65.7K |
|
|
SSLY
5529
DELISTED
Syntax Stratified SmallCap ETF
SSLY
| $227K | ﹤0.01% |
+5,000
| New | +$218K |
|
5530
Smith Douglas Homes
SDHC
$124M
| $225K | ﹤0.01% |
+7,577
| New | +$212K |
|
5531
Abeona Therapeutics
ABEO
$389M
| $225K | ﹤0.01% |
31,035
-627
| -2% | -$3.97K |
|
|
FORTY
5532
Formula Systems
FORTY
$1.6B
| $225K | ﹤0.01% |
2,907
-2,907
| -50% | -$211K |
|
5533
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$213M
| $225K | ﹤0.01% |
3,467
-5,559
| -62% | -$355K |
|
5534
UNIFI
UFI
$119M
| $224K | ﹤0.01% |
37,367
-33,147
| -47% | -$201K |
|
5535
Palmer Square Capital BDC
PSBD
$303M
| $223K | ﹤0.01% |
+13,695
| New | +$223K |
|
|
CLLS
5536
Cellectis
CLLS
$277M
| $223K | ﹤0.01% |
84,145
-68,305
| -45% | -$189K |
|
5537
WisdomTree US Efficient Core Fund
NTSX
$1.4B
| $221K | ﹤0.01% |
5,226
-3,702
| -41% | -$151K |
|
5538
Hurco Companies Inc
HURC
$142M
| $220K | ﹤0.01% |
10,935
-9,975
| -48% | -$235K |
|
|
CAN
5539
Canaan Creative
CAN
$149M
| $220K | ﹤0.01% |
144,868
-268,698
| -65% | -$456K |
|
5540
ProShares UltraShort S&P500
SDS
$391M
| $220K | ﹤0.01% |
1,769
-8,841
| -83% | -$1.22M |
|
5541
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.58B
| $219K | ﹤0.01% |
+164,981
| New | +$245K |
|
|
VTRU
5542
DELISTED
Vitru Limited Common Shares
VTRU
| $219K | ﹤0.01% |
14,542
-19,408
| -57% | -$277K |
|
5543
Lexeo Therapeutics
LXEO
$330M
| $219K | ﹤0.01% |
13,944
-5,032
| -27% | -$78.7K |
|
5544
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund
FDTS
$13.5M
| $219K | ﹤0.01% |
5,172
-8,054
| -61% | -$327K |
|
5545
Protalix BioTherapeutics
PLX
$187M
| $218K | ﹤0.01% |
173,071
-325,929
| -65% | -$487K |
|
5546
StealthGas
GASS
$329M
| $216K | ﹤0.01% |
36,405
-87,531
| -71% | -$590K |
|
5547
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.4M
| $215K | ﹤0.01% |
6,130
-66
| -1% | -$2.48K |
|
5548
Electromed
ELMD
$344M
| $215K | ﹤0.01% |
13,284
-23,658
| -64% | -$311K |
|
5549
Evogene
EVGN
$7.87M
| $213K | ﹤0.01% |
28,405
-9,284
| -25% | -$77.4K |
|
5550
Putnam Focused Large Cap Value ETF
PVAL
$13.7B
| $212K | ﹤0.01% |
+5,935
| New | +$196K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.